These consistent findings suggest that the expression of PBX2, PRMT1, SMARCC1, and IGF2BP2 in tumor tissues could serve as reliable diagnostic markers for HNSCC due to their high sensitivity and specificity. The gene discussed is SMARCC1; the disease is neoplasm.